BACIL Pharma has set its book closure period from September 17 to September 23 for the upcoming 39th Annual General Meeting.

During this period, only shareholders registered on record by the close of business on September 16 will be eligible to attend and vote at the AGM, which is scheduled for September 23. The company also clarified that no dividend has been declared for the financial year 2025-2026. This is an important update for investors to ensure their eligibility to participate in key company decisions.